Skip to main content
Filing year 2024

INTERNATIONAL SOCIETY FOR PHARMACOECONOMICS OUTCOMES RESEARCH

Lawrenceville, New Jersey·EIN 22-3369741·NTEE H02 · Medical Research·501(c)(3)
Total revenue
$19.7M
Total assets
$30.2M
Total expenses
$19.4M
Reported officers
22
Mission

THE MISSION OF INTERNATIONAL SOCIETY FOR PHARMACOECONOMICS OUTCOMES RESEARCH (ISPOR) IS TO PROMOTE HEALTH ECONOMICS AND OUTCOMES RESEARCH EXCELLENCE TO IMPROVE DECISION MAKING FOR HEALTH GLOBALLY.

Executive compensation, broken down

Form 990 · Part VII & Schedule J · 6 reported individuals · Filing year 2024

Percentile bands compare each position's total pay with the same role at Medical Research organizations nationwide.

Chief Operating Officer
75th to 90th percentile
$346k
$374k
Base
$267k
Bonus
$50k
Other
Benefits
$9k
Chief Science Officer
Highest Compensated Employee
75th to 90th percentile
$331k
$357k
Base
$266k
Bonus
$53k
Other
Benefits
Chief Marketing Officer
Highest Compensated Employee
Median to 75th percentile
$265k
$287k
Base
$211k
Bonus
$23k
Other
Benefits
$21k
Director, Business Development
75th to 90th percentile
$260k
$280k
Base
$139k
Bonus
$84k
Other
Benefits
$25k
Chief Info & Engagement Officer
Highest Compensated Employee
Median to 75th percentile
$236k
$255k
Base
$199k
Bonus
$3k
Other
Benefits
$33k
Director, Global Events
Highest Compensated Employee
Median to 75th percentile
$226k
$245k
Base
$180k
Bonus
$25k
Other
Benefits
$9k

Teal figures restate each filed amount in 2026 dollars.

Estimated with BLS CPI-U for the Northeast region, restating filed pay into May 2026 dollars. A restatement of past pay, not current or projected pay.

Plus 16 unpaid individuals.

Browse compensation in Medical Research

Pay in context

Top pay as a share of expenses

In 2024, the highest total compensation at INTERNATIONAL SOCIETY FOR PHARMACOECONOMICS OUTCOMES RESEARCH equaled 2% of the organization's total expenses. The median for medical research organizations is 10%.

This organization (2024)
2%
Sector median
10%
Middle half of sector
4% to 21%

Based on 1,118 medical research organizations, each measured at its most recent filing year with reported expenses and compensation.

Down 16%
from 2023

From $411k in 2023 to $346k in 2024.

$411k
2023
$346k
2024
In today's dollarsEst.
Down 18% in real terms$459k to $374k

Estimated with BLS CPI-U for the Northeast region, restating filed pay into May 2026 dollars. A restatement of past pay, not current or projected pay.

Pay for the position

Chief Operating Officer pay fell 16% from 2023 to 2024, while revenue rose 7%.

$411k in 2023 to $346k in 2024.
  • Highest Compensated Employee pay fell 7% from 2023 to 2024.

Pay for the position itself, not any one person. The officeholder may have changed between 2023 and 2024.

Highest reported compensation in each year. Volunteer board members and partial-year payouts are filtered out.

Among peers

Revenue and top compensation, plotted against similar organizations. This organization is highlighted in cyan.

1
NEW JERSEY HEALTH FOUNDATION INC2024
$623k
2
INTERNATIONAL SOCIETY FOR PHARMACOECONOMICS OUTCOMES RESEARCH2024
$346k
3
CHRISTOPHER REEVE FOUNDATION2023
$191k
See full COO compensation rankings across Medical Research
FAQ

Common questions about INTERNATIONAL SOCIETY FOR PHARMACOECONOMICS OUTCOMES RESEARCH

What does the Chief Operating Officer of INTERNATIONAL SOCIETY FOR PHARMACOECONOMICS OUTCOMES RESEARCH earn?

In 2024, the Chief Operating Officer of INTERNATIONAL SOCIETY FOR PHARMACOECONOMICS OUTCOMES RESEARCH received $346,150 in total compensation. This pay is in the top quarter for Chief Operating Officer roles among Medical Research organizations nationwide, though not the top 10% of comparable filings. Based on IRS Form 990 data.

How does Chief Operating Officer pay at INTERNATIONAL SOCIETY FOR PHARMACOECONOMICS OUTCOMES RESEARCH compare with similar nonprofits?

Compared with the same role at Medical Research organizations nationwide, the 2024 pay of the Chief Operating Officer at INTERNATIONAL SOCIETY FOR PHARMACOECONOMICS OUTCOMES RESEARCH falls between the 75th and 90th percentiles. In 2024, the highest total compensation at INTERNATIONAL SOCIETY FOR PHARMACOECONOMICS OUTCOMES RESEARCH equaled 2% of the organization's total expenses. The median for medical research organizations is 10%.

What are INTERNATIONAL SOCIETY FOR PHARMACOECONOMICS OUTCOMES RESEARCH's revenue and expenses?

In 2024, INTERNATIONAL SOCIETY FOR PHARMACOECONOMICS OUTCOMES RESEARCH reported $19.7M in total revenue and $19.4M in total expenses on its IRS Form 990.

Free, forever
Build lists. Save your benchmarks.
A free Lucido account lets you build lists of nonprofits and save your search filters. No credit card.
Already a member? Sign in
Build a benchmark

Compare any role, sector, or revenue band

Build your own benchmark from millions of reported positions.